Prescription pattern of antihypertensive drugs in a tertiary care teaching hospital

Shanmugapriyan S; Rajesh M; Parimala K; Nithya P; Jaikumar S

Authors

Shanmugapriyan S Assistant professor, Department of Pharmacology, Meenakshi Medical College & Research Institute, Meenakshi Academy of Higher Education and Research (MAHER), Kanchipuram, Tamilnadu, India
Rajesh M Department of Pharmacology, Meenakshi Medical College & Research Institute, Meenakshi Academy of Higher Education and Research (MAHER), Kanchipuram, Tamilnadu, India
Parimala K Department of Pharmacology, Meenakshi Medical College & Research Institute, Meenakshi Academy of Higher Education and Research (MAHER), Kanchipuram, Tamilnadu, India
Nithya P Department of Pharmacology, Meenakshi Medical College & Research Institute, Meenakshi Academy of Higher Education and Research (MAHER), Kanchipuram, Tamilnadu, India
Jaikumar S Department of Pharmacology, Meenakshi Medical College & Research Institute, Meenakshi Academy of Higher Education and Research (MAHER), Kanchipuram, Tamilnadu, India

Keywords:

Antihypertensive drugs, Monotherapy, Combination Therapy

Abstract

Background: Hypertension is one of the modifiable risk factors for cardiovascular and kidney disease and has been identified to contribute significantly to cardiovascular mortality. Objective: To evaluate the prescribing pattern of antihypertensive drugs in a tertiary care teaching hospital. Materials and Methods: A retrospective analysis was carried out from in patients in a tertiary care hospital, Kanchipuram to access the prescription pattern of antihypertensive drugs during June 2018 to December 2018. Results: In the present study, the percentage of monotherapy and combination therapy was 46.49% and 53.51% respectively. Beta blockers was the most commonly prescribed drug as monotherapy and beta blockers + Calcium channel blockers (CCB) were the most commonly prescribed drug among combination therapy. Conclusion: In the present study combinational therapy was considered to be more effective in the management of hypertension over monotherapy.